About
Micrima Limited is a UK-based medical technology company founded in 2005 and headquartered in Bristol. The company specializes in breast cancer diagnosis and breast tissue analysis, utilizing radio-frequency and microwave radar technology originally adapted from landmine detection. Micrima aims to enhance early detection and risk assessment of breast cancer through innovative diagnostic tools. The core product of Micrima is the MARIA system, a microwave radar breast imaging device currently in clinical trials. This system employs AI to analyze breast tissue properties, including breast density, which is crucial for assessing cancer risk. The technology offers instant breast tissue analysis, a breast cancer risk calculator, and improved ergonomics for users. Micrima's solutions are designed for healthcare providers, breast screening programs, and clinicians, supporting personalized medicine approaches in breast health. The company is actively conducting clinical trials to validate its technology and collaborates with healthcare professionals to meet clinical needs and regulatory standards.
Technologies
Keywords
Company Information
-
Employees 27
-
Founded 2005
-
Annual Revenue $5000000
-
Total Funding $16942078
Location
2 Glass Wharf, England, United Kingdom, BS2 0PS